News

Company News: Curetis To Attend Key Investor and Scientific Conferences In The First Quarter 2018

Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that the Company is going to attend several industry conferences in the first quarter of 2018.

January:

J.P. Morgan 36th Annual Healthcare Conference, January 08-10, 2018 – San Francisco, CA, USA – one-on-one investor meetings

Reanimation Congress 2018, January 24-26, 2018 – Paris, France: booth number 43b, Hall 7, Congress Centre: Paris Expo – Porte de Versailles

February:

Degroof Petercam Life Sciences Investor Day, February 01, 2018 – Brussels, Belgium – one-on-one investor meetings

BioCapital Europe, February 06, 2018 – Amsterdam, The Netherlands – company presentation and one-on-one investor meetings

28^th Syposium Intensivmedizin + Intensivpflege, February 14-16, 2018 – Bremen, Germany: booth number S15, Hall 4, Congress Centre: Messe Bremen

DGHM 2018 – 70^th Annual Meeting of the German Society for Hygiene and Microbiology, February 19-21, 2018 – Bochum, Germany: booth number 12,

Ruhr-Universitaet Bochum

March:

11th Berlin Conference on Life Sciences – Novel Antimicrobials and AMR Diagnostics, March 02, 2018 – Berlin, Germany